This page was last updated on 23 June 2025. The supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 analogues) have now been reported as resolved. We had been concerned ...

Ingredients 400g tin chickpeas, drained and rinsed 300g pack cooked beetroot in natural juices/water, drained 1 clove garlic, crushed pinch cayenne pepper 1 tsp cumin freshly ground black pepper 2 tsp ...

If you come from a South Asian background you are at a higher risk of developing Type 2 diabetes. Diabetes is serious but the good news is that there are a number of ways you can reduce your risk of ...

2023 - TREND UK press release Trend UK has published an insulin safety leaflet. The patient booklet is entitled Keeping Safe with Insulin Therapy because “insulin management and prescribing errors are ...

There are some very early clues to suggest that coronavirus might be triggering type 1 or type 2 diabetes in some people, or making the condition worse for others. We take a look at the evidence and ...

Causes of type 1 diabetes It’s normal to wonder if something you’ve done could have caused your type 1 diabetes – or a child’s type 1 diabetes. But there’s nothing you could have done to prevent it.

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

Scientists in the United States have announced early results from a pioneering trial testing a new stem cell treatment designed to replace insulin-producing beta cells in people with type 1 diabetes.

We're going to explore whether an intermittent fasting diet can help you put your type 2 diabetes into remission. What are intermitten ...

In some areas of the UK, there are type 2 diabetes remission programmes available through the NHS and health boards. Not every area has a specific type 2 remission programme available, and where there ...

We take a look at some of the exciting diabetes research developments announced in October, and what the findings could mean for people living with or affected by diabetes.

The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...